Clinical Trial Update: Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial of full-dose atorvastatin after acute coronary syndrome in patients with non-revascularisable coronary artery disease has been terminated, per t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: San Filippo Neri General Hospital | Conditions: Acute Coronary Syndrome, Coronary Artery Disease | Phase 3 | Status: TERMINATED